CD209 and colorectal carcinoma: The miR-185 repression of DC-SIGN prevents β-catenin translocation to the nucleus of CRC cells by inactivation of the PI3K/Akt/GSK-3β pathway and the DC-SIGN/TCF1/LEF1 pathway could directly downregulate miR-185 in CRC.